Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$68.62 0.68 (1%) as of 4:30 Wed 3/27


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 98.13(B)
Last Volume: 4,069,742 Avg Vol: 8,519,891
52 Week Range: $47.94 - $67.82
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 199,132 469,488 885,133 1,877,631
Total Sell Value $12,080,496 $26,266,302 $48,317,781 $91,052,440
Total People Sold 6 7 10 15
Total Sell Transactions 12 19 36 74
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 1828
  Page 7 of 74  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2014-02-16 4 D $13.30 $54,011 D/D (4,061) 66,600     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 11,471 70,661     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2014-02-16 4 D $13.30 $25,563 D/D (1,922) 28,799     -
   Pierce David A SVP and President, Endoscopy   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 5,121 30,721     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2014-02-16 4 D $13.30 $23,860 D/D (1,794) 86,884     -
   Fitzgerald Joseph Michael SVP & President, CRM   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 4,723 88,678     -
   Pucel Kenneth EVP, Glob Ops, Qual & Tech   •       •      –    2014-02-16 4 D $13.30 $31,667 D/D (2,381) 137,000     -
   Pucel Kenneth EVP, Glob Ops, Qual & Tech   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 6,747 139,381     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2014-02-16 4 D $13.30 $53,666 D/D (4,035) 53,214     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 11,471 57,249     -
   Phalen Michael P. EVP & President, MedSurg   •       •      –    2014-02-16 4 D $13.30 $19,963 D/D (1,501) 87,522     -
   Phalen Michael P. EVP & President, MedSurg   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 4,723 89,023     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2014-02-16 4 D $13.30 $16,199 D/D (1,218) 83,957     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 3,373 85,175     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       •      –    2014-02-16 4 D $13.30 $23,741 D/D (1,785) 89,777     -
   Lance Jean Fitterer SVP & Chief Compliance Officer   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 4,588 91,562     -
   Brennan Daniel J. EVP and CFO   •       •      –    2014-02-16 4 D $13.30 $22,131 D/D (1,664) 71,310     -
   Brennan Daniel J. EVP and CFO   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 4,487 72,974     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2014-02-16 4 D $13.30 $12,356 D/D (929) 81,718     -
   Nanavaty Maulik SVP & Pres, Neuromodulation   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 2,115 82,647     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       •      –    2014-02-16 4 D $13.30 $123,770 D/D (9,306) 138,139     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       •      –    2014-02-16 4 OE $0.00 $0 D/D 28,434 147,445     -
   Sununu John E Director   •       •      –    2014-02-14 4 S $13.17 $389,318 D/D (29,561) 18,997     -
   Johnson Kristina M Director   •       •      –    2014-02-13 4 S $13.01 $234,106 D/D (18,000) 3,124     -
   Nicholas Nicholas J Jr Director   •       •      –    2014-02-07 4 GD $0.00 $0 I/I 10,000 4,600     -

  1828 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 74
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed